The Gene Expression of Proteins Involved in Intercellular Signaling and Neurodegeneration in the Substantia Nigra in a Mouse Subchronic Model of Parkinson’s Disease

The Gene Expression of Proteins Involved in Intercellular Signaling and Neurodegeneration in the Substantia Nigra in a Mouse Subchronic Model of Parkinson’s Disease

Given the limited access to clinical material for studying the pathogenesis of Parkinson’s disease (PD), these studies should be carried out on experimental models. We have recently developed a subchronic model of the progressive development of PD with a gradual transition from the preclinical (asym...

Full description

Bibliographic Details
Main Authors:	Anna Kolacheva, Ekaterina Pavlova, Alyona Bannikova, Vsevolod Bogdanov, Dmitry Troshev, Michael Ugrumov
Format:	Article
Language:	English
Published:	MDPI AG 2023-02-01
Series:	International Journal of Molecular Sciences
Subjects:	Parkinson’s disease modeling of Parkinson’s disease dopaminergic neurons substantia nigra neurodegeneration gene expression
Online Access:	https://www.mdpi.com/1422-0067/24/3/3027

Similar Items

Initial Molecular Mechanisms of the Pathogenesis of Parkinson’s Disease in a Mouse Neurotoxic Model of the Earliest Preclinical Stage of This Disease
by: Anna Kolacheva, et al.
Published: (2024-01-01)

Modeling of the Progressive Degradation of the Nigrostriatal Dopaminergic System in Mice to Study the Mechanisms of Neurodegeneration and Neuroplasticity in Parkinson’s Disease
by: Anna Kolacheva, et al.
Published: (2022-12-01)

Application of OpenArray Technology to Assess Changes in the Expression of Functionally Significant Genes in the Substantia Nigra of Mice in a Model of Parkinson’s Disease
by: Dmitry Troshev, et al.
Published: (2023-12-01)

Substantia Nigra Hyperechogenicity Reflects the Progression of Dopaminergic Neurodegeneration in 6-OHDA Rat Model of Parkinson’s Disease
by: Siyan Zhang, et al.
Published: (2020-08-01)

Isolation of living dopaminergic neurons labeled with a fluorescent ligand of the dopamine transporter from mouse substantia nigra as a new tool for basic and applied research
by: Dmitry Troshev, et al.
Published: (2022-12-01)

Altered expression patterns of inflammation-associated and trophic molecules in substantia nigra and striatum brain samples from Parkinson’s disease, incidental Lewy body disease and normal control cases
by: Douglas Gordon Walker, et al.
Published: (2016-01-01)

Characterization of substantia nigra neurogenesis in homeostasis and dopaminergic degeneration: beneficial effects of the microneurotrophin BNN-20
by: Theodora Mourtzi, et al.
Published: (2021-06-01)

Ninetieth Anniversary of Parkinson’s Disease «Substantia Nigra» Theory
by: O.N. Voskresenskaya, et al.
Published: (2009-06-01)

Cognitive performance patterns in healthy individuals with substantia nigra hyperechogenicity and early Parkinson’s disease
by: Rezzak Yilmaz, et al.
Published: (2016-11-01)

The application value of quantitative susceptibility mapping in evaluating substantia nigra "swallow tail sign" in the diagnosis of Parkinson's disease
by: Xiao-jun GUAN, et al.
Published: (2018-04-01)

Semi-Automatic Signature-Based Segmentation Method for Quantification of Neuromelanin in Substantia Nigra
by: Gašper Zupan, et al.
Published: (2019-11-01)

Increased Serum Lithium Level due to Mild to Moderate damage to Dopaminergic Neurons of the Substantia Nigra, Evidence from Animal Model of Parkinson’s Disease induced by 6-Hydoxydopamine
by: Mohammad Hossein Esmaeili, et al.
Published: (2022-12-01)

Automated Assessment of the Substantia Nigra Pars Compacta in Parkinson’s Disease: A Diffusion Tensor Imaging Study
by: Niels Bergsland, et al.
Published: (2021-11-01)

Explorative Combined Lipid and Transcriptomic Profiling of Substantia Nigra and Putamen in Parkinson’s Disease
by: Helena Xicoy, et al.
Published: (2020-08-01)

Irisin protect the Dopaminergic neurons of the Substantia nigra in the rat model of Parkinson’s disease
by: Sam Zarbakhsh, et al.
Published: (2019-07-01)

Transcranial Sonographic Alterations of Substantia Nigra and Third Ventricle in Parkinson's Disease with or without Dementia
by: Zhi-Fen Dong, et al.
Published: (2017-01-01)

Minocycline reduces the lipopolysaccharide-induced inflammatory reaction, peroxynitrite-mediated nitration of proteins, disruption of the blood–brain barrier, and damage in the nigral dopaminergic system
by: Mayka Tomás-Camardiel, et al.
Published: (2004-06-01)

Locus coeruleus and substantia nigra neuromelanin magnetic resonance imaging differentiates Parkinson’s disease and essential tremor
by: Xinhui Wang, et al.
Published: (2023-01-01)

Picornavirus May Be Linked to Parkinson’s Disease through Viral Antigen in Dopamine-Containing Neurons of Substantia Nigra
by: Bo Niklasson, et al.
Published: (2022-03-01)

MRI T2 and T2* relaxometry to visualize neuromelanin in the dorsal substantia nigra pars compacta
by: Hansol Lee, et al.
Published: (2020-05-01)

Magnetic resonance spectroscopy imaging of medulla oblongata and substantia nigra in idiopathic Parkinson's disease
by: Netra Rana
Published: (2013-06-01)

Neuromelanin magnetic resonance imaging of substantia nigra and locus coeruleus in Parkinson’s disease with freezing of gait
by: Shangpei Wang, et al.
Published: (2023-02-01)

Different methylation of the TNF-alpha promoter in cortex and substantia nigra: Implications for selective neuronal vulnerability
by: Heike C. Pieper, et al.
Published: (2008-12-01)

Chemical Exchange Saturation Transfer MRI Signal Loss of the Substantia Nigra as an Imaging Biomarker to Evaluate the Diagnosis and Severity of Parkinson's Disease
by: Chunmei Li, et al.
Published: (2017-08-01)

The Effect of Compulsory Sports Activities on Substantia Nigra Tissue and Behavioral Tests Induction Parkinsons Model with 6-Hydroxydopamine in Prenatal Stress Rats
by: Toraj Mohammad zamani, et al.
Published: (2019-03-01)

Altered Tracer Distribution and Clearance in the Extracellular Space of the Substantia Nigra in a Rodent Model of Parkinson's Disease
by: Yuan Fang, et al.
Published: (2017-07-01)

Changes in Tyrosine Hydroxylase Activity and Dopamine Synthesis in the Nigrostriatal System of Mice in an Acute Model of Parkinson’s Disease as a Manifestation of Neurodegeneration and Neuroplasticity
by: Anna Kolacheva, et al.
Published: (2022-06-01)

Nigral transcriptomic profiles in Engrailed-1 hemizygous mouse models of Parkinson’s disease reveal upregulation of oxidative phosphorylation-related genes associated with delayed dopaminergic neurodegeneration
by: Lautaro Francisco Belfiori, et al.
Published: (2024-02-01)

An investigation of neuromelanin distribution in substantia nigra and locus coeruleus in patients with Parkinson’s disease using neuromelanin-sensitive MRI
by: Qiang Liu, et al.
Published: (2023-08-01)

MPTP and DSP-4 susceptibility of substantia nigra and locus coeruleus catecholaminergic neurons in mice is independent of parkin activity
by: Bobby Thomas, et al.
Published: (2007-05-01)

Combined Stimulation of the Substantia Nigra and the Subthalamic Nucleus for the Treatment of Refractory Gait Disturbances in Parkinson’s Disease: A Preliminary Study
by: Marta Villadóniga, et al.
Published: (2022-04-01)

Corrigendum: USP14 as a therapeutic target against neurodegeneration: a rat brain perspective
by: Chayan Banerjee, et al.
Published: (2023-07-01)

The Effects of Enriched Environment on Substantia nigra Tissue in Parkinson’s Disease Rats with Prenatal Stress
by: Toraj Mohammad zamani, et al.
Published: (2019-01-01)

Meta-Analysis of Differentially Expressed Genes in the Substantia Nigra in Parkinson’s Disease Supports Phenotype-Specific Transcriptome Changes
by: Duong My Phung, et al.
Published: (2020-12-01)

Short-echo-time magnitude image derived from quantitative susceptibility mapping could resemble neuromelanin-sensitive MRI image in substantia nigra
by: Xue Ling Liu, et al.
Published: (2020-06-01)

Combined Visualization of Nigrosome-1 and Neuromelanin in the Substantia Nigra Using 3T MRI for the Differential Diagnosis of Essential Tremor and de novo Parkinson's Disease
by: Lirong Jin, et al.
Published: (2019-02-01)

TRPC3 and NALCN channels drive pacemaking in substantia nigra dopaminergic neurons
by: Ki Bum Um, et al.
Published: (2021-08-01)

Post-mortem brain histological examination in the substantia nigra and subthalamic nucleus in Parkinson’s disease following deep brain stimulation
by: Srestha Mazumder, et al.
Published: (2022-09-01)

Cerebral Dopamine Neurotrophic Factor Diffuses Around the Brainstem and Does Not Undergo Anterograde Transport After Injection to the Substantia Nigra
by: Katrina Albert, et al.
Published: (2019-06-01)

The role of substantia nigra sonography in the differentiation of Parkinson’s disease and multiple system atrophy
by: Hai-Yan Zhou, et al.
Published: (2018-07-01)